Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding novel ways to treat immune disorders and blood diseases, and developing new animal models for heart failure, diabetes and neurodegenerative diseases. The grants, …
Pat Levitt, PhD, Children’s Hospital Los Angeles’ (CHLA) Chief Scientific Officer and Director of The Saban Research Institute, has been appointed to the board that oversees the California Institute for Regenerative Medicine (CIRM). CIRM is the voter-created agency that funds stem cell research at institutions and organizations throughout the state. “Dr. Levitt will bring a …
Story courtesy of Children’s Hospital Los Angeles Pat Levitt, PhD, Chief Scientific Officer at Children’s Hospital Los Angeles and Simms/Mann Chair in Developmental Neurogenetics, received a $3.7M grant from the National Institute of Mental Health to study development of neural circuits. “Our laboratory investigates how the wiring of the brain that underlies cognition and social …
Story courtesy of Children’s Hospital Los Angeles A study of 70 mothers and their infants suggests that the impact of maternal stress on neurodevelopment is detectable by electroencephalography (EEG) at 2 months of age. The team of investigators, co-led by Pat Levitt, PhD, of Children’s Hospital Los Angeles, and Charles A. Nelson, PhD, of Boston …
Investigators found that many common psychiatric disorders are deeply connected on a genetic level, sharing specific genetic risk factors, underscoring the need to recognize shared dimensions of brain dysfunction, and develop new treatment strategies. Results of this investigation have been published in the June 22, 2018 issue of the journal, Science.
Pat Levitt, PhD, has been named Vice President, Chief Scientific Officer and Director of The Saban Research Institute of Children’s Hospital Los Angeles.
Pat Levitt, provost professor of pediatrics, neuroscience, psychiatry, psychology and pharmacy at the Keck School of Medicine of USC, was recently elected as a member into the prestigious Institute of Medicine (IOM), part of the National Academy of Sciences. The IOM is an independent non-governmental organization that provides unbiased, expert advice to policy makers and …
Los Angeles businessman and Keck School of Medicine Board of Overseers Member Selim Zilkha recently reaffirmed his commitment to the Keck School center that bears his name with a $5 million gift. The donation will support the Zilkha Neurogenetic Institute (ZNI) and will be used for recruitment of senior scientists and investigators to the institute.
